Top Tweets for #ASGCTYearInReview
#ASGCTYearinReview Get the latest on #CRISPR & #geneediting at #ASGCT23! Hear Jennifer Doudna, PhD, TMRW (5/17, 1:30 pm PT) at the Presidential Symposium & See video below, where long-time member @NucleaseLab, talks about gene editing https://t.co/SOMEn7gfcQ
#ASGCTYearinReview Congratulations to our #ASGCT23 Outstanding Poster Presentation Award recipients! Check out the abstracts behind the top 30 poster presentations at the 26th Annual Meeting. https://t.co/dOv2YF42yZ
Happy holidays, ASGCT members & friends! Our office is closed Dec. 25-Jan. 1, but while we're gone you can: register for #ASGCT24, submit an abstract, renew your membership, etc.
Meanwhile, we'll share our top 2023 posts at #ASGCTYearinReview - let us know your favorites!
#ASGCTYearInReview: In 2022, ASGCT's #PatientEducation team updated many patient- and clinician-centered resources with the latest #genetherapy and #celltherapy research. Check out the units and watch the community Lunch & Learn videos on demand: https://t.co/xsV0bdnSPy
#ASGCTYearInReview: If you're a patient, advocate, or caregiver seeking #genetherapy research for a #raredisease, check out our list of gene therapy centers in the U.S., compiled by ASGCT Patient Education: https://t.co/lOJqHz916w
#ASGCTYearInReview: In April, #FDA granted fast track designation to an investigational gene-edited cell-based therapy for the treatment of women with metastatic #breastcancer
https://t.co/6FZoKWQ4XU
#celltherapy
#ASGCTYearInReview: In October, we launched ASGCT's first #podcast, Giants of Gene Therapy. Society President @HPKiem, MD, PhD, regularly interviews luminaries in cell & gene therapy. Search “ASGCT” in your favorite podcast app to subscribe!
https://t.co/yj7fQgONEQ
#ASGCTYearInReview: According to May report, lentiviral #genetherapy for infants with X-SCID appeared to be safe and effective at a median follow up of over 2.5 years, said ASGCT Member Ewelina Mamcarz, MD. Results were presented at ASGCT's Annual Meeting https://t.co/hgeN56cNF7
#ASGCTYearInReview: Preliminary data presented by ASGCT Member Roger Hajjar, MD, at the 2022 Annual Meeting showed #genetherapy to treat congestive heart failure had 30 times higher uptake in human hearts compared to pig hearts, at just 1/10 of the dose. https://t.co/QGmh0Emljo
#ASGCTYearInReview: The Annual Meeting is the premier event for professionals in cell & gene therapy. Register for #ASGCT23 now! Hear from our members and elected leadership why this community is essential & why new scientists should invest time in ASGCT https://t.co/uYEOOnXh9v
#ASGCTYearInReview: The Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more. Learn more from ASGCT and @Citeline (formerly Pharma Intelligence)
https://t.co/AqyjqVzBNK
#ASGCTYearInReview: During the 2022 ASGCT Annual Meeting, companies shared results on the clinical development of their #genetherapy trials. In this October GEN piece, representatives provided updates, expanding on their results: https://t.co/hTVPeuOB4v.
#ASGCTYearInReview: The #FDA approved the first #genetherapy for bladder cancer, one of the most common forms of cancer. Adstiladrin is for adults who aren't responsive to immunotherapy — and have few other treatment options. Learn more from our blog.
https://t.co/FWyQCMKAtb
#ASGCTYearInReview: In November, #FDA approved the first #genetherapy to treat adults with #HemophiliaB — Hemgenix (etranacogene dezaparvovec)! Learn more about the treatment on our blog.
https://t.co/E7qi76binw.
#ASGCTYearInReview: A new #genetherapy was approved by #FDA in September! SKYSONA, approved a month after Zynteglo, is the second lentiviral vector gene therapy in the U.S. and the first for cerebral adrenoleukodystrophy (#CALD). Learn more on our blog.
https://t.co/YsNRxeBgvD
We're highlighting the top posts of 2022 with #ASGCTYearInReview. In August, beticel (Zynteglo) became the first lentiviral vector #genetherapy in the U.S.! Read the details on our blog. #BetaThalassemia
https://t.co/AfOkdYy6Zf
#ASGCTYearinReview: Paloma Giangrande, PhD (@Giangran1Paloma) will be the next editor-in-chief of @MolTherapy Nucleic Acids! Read our blog post to learn about her goals for the next five years and her ability to push herself out of her comfort zone. https://t.co/Vp9xpcryit
#ASGCTYearinReview: One patient who received a #stemcell therapy to treat type 1 #diabetes (#T1D) showed signs that the body was producing insulin on its own. https://t.co/oqyYgebWov
#ASGCTYearinReview: Congratulations to ASGCT Member Carl June, M.D. (@PennMedicine), who has been named a 2021 Dan David Prize Laureate! June was recognized for his contributions to molecular medicine, including groundbreaking work in #CART #celltherapy. https://t.co/2nQHvVZwuf
#ASGCTYearinReview: New on the blog: During last week's seminar, @Nicole_Paulk gave us five tips for successfully using Twitter to bring awareness to your scientific area of interest! Check them out here. #scitwitter https://t.co/2FvTlSGtRx
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers